NuCana plc

US$0.94As of Sun 8 Nov 2026, 12:00 UTC
LSE:FUMHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 9Y CAGR (71.69%)
Div yield —
ROE (145.13%)
Biotechnology
Beta (5Y) 2.44
PE TTM —
TSR TTM (76.62%)
Mkt cap US$4.041M
ROIC (76.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.05
12.25%
110.18%
Sell 2|4|10|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.01
0.01
0.01
0.01
10.14%
8.52%
21.45%
23.92%
Revenue£M
0.437
0.448
0.464
0.482
0.71%
0.02%
3.10%
7.23%
Peers (US$4.169M)
Cap (US$)
PE
6.316M
—
4.041M
—
3.863M
—
4.110M
—
Capital
TTM
5Y
10Y
Leveragex
4.039
(0.037)
(0.039)
EBIT/Intx
3.376
4.237
3.553
Own earn%
89.01
(57.38)
(50.85)
Sh yield%
30.69
22.94
22.88
Owners
Insiders/Inst%
8.49
56.58
Short interest%
5.77
SBC / revenue%
4.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
20–26
$1 testx
0.1
Incr. ROIC%
10